Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
6.19
+0.01 (0.16%)
At close: Jun 24, 2026, 4:00 PM EDT
6.32
+0.13 (2.10%)
After-hours: Jun 24, 2026, 7:35 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.53 billion as of June 24, 2026. Its market cap has increased by 69.98% in one year.
Market Cap
1.53B
Enterprise Value
1.53B
1-Year Change
69.98%
Ranking
Category
Stock Price
$6.19
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.53B, an increase of 530.04%. That is a compound annual growth rate of 16.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 1.53B | 7.95% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.55B |
| Vir Biotechnology | 1.54B |
| Ascentage Pharma Group International | 1.54B |
| Bicara Therapeutics | 1.53B |
| GH Research | 1.53B |
| Novavax | 1.50B |
| SELLAS Life Sciences Group | 1.50B |
| AtaiBeckley | 1.49B |